Cargando…
A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
BACKGROUND: Central pontine myelinolysis (CPM) is a rare demyelinating disorder caused by the loss of myelin in the center of the basis pontis. CPM typically occurs with rapid correction of severe chronic hyponatremia and subsequent disturbances in serum osmolality. Although hyperglycaemia is recogn...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170667/ https://www.ncbi.nlm.nih.gov/pubmed/37165361 http://dx.doi.org/10.1186/s12902-023-01361-y |
_version_ | 1785039270816251904 |
---|---|
author | Sun, Wen-Ping Wang, Ying-Di Gao, Song Wang, Yi-Fan Li, Da-Wei |
author_facet | Sun, Wen-Ping Wang, Ying-Di Gao, Song Wang, Yi-Fan Li, Da-Wei |
author_sort | Sun, Wen-Ping |
collection | PubMed |
description | BACKGROUND: Central pontine myelinolysis (CPM) is a rare demyelinating disorder caused by the loss of myelin in the center of the basis pontis. CPM typically occurs with rapid correction of severe chronic hyponatremia and subsequent disturbances in serum osmolality. Although hyperglycaemia is recognized as a pathogenetic factor in serum osmolality fluctuations, CPM is rarely seen in the context of diabetes. CASE PRESENTATION: A 66-year-old Chinese male presented with a history of gait imbalance, mild slurred speech and dysphagia for two weeks. MRI showed the mass lesions in the brainstem, and laboratory examinations showed high blood glucose and HbA1c, as well as increased serum osmolality. The patient was diagnosed with CPM secondary to hyperosmolar hyperglyceamia and received insulin treatment as well as supportive therapy. After six weeks of followup, the patient had fully recovered to a normal state. CONCLUSION: CPM is a potentially fatal neurological condition and can occur in uncontrolled diabetes mellitus. Early diagnosis and timely treatment are crucial for improving the prognosis. |
format | Online Article Text |
id | pubmed-10170667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101706672023-05-11 A rare presentation of central pontine myelinolysis secondary to hyperglycaemia Sun, Wen-Ping Wang, Ying-Di Gao, Song Wang, Yi-Fan Li, Da-Wei BMC Endocr Disord Case Report BACKGROUND: Central pontine myelinolysis (CPM) is a rare demyelinating disorder caused by the loss of myelin in the center of the basis pontis. CPM typically occurs with rapid correction of severe chronic hyponatremia and subsequent disturbances in serum osmolality. Although hyperglycaemia is recognized as a pathogenetic factor in serum osmolality fluctuations, CPM is rarely seen in the context of diabetes. CASE PRESENTATION: A 66-year-old Chinese male presented with a history of gait imbalance, mild slurred speech and dysphagia for two weeks. MRI showed the mass lesions in the brainstem, and laboratory examinations showed high blood glucose and HbA1c, as well as increased serum osmolality. The patient was diagnosed with CPM secondary to hyperosmolar hyperglyceamia and received insulin treatment as well as supportive therapy. After six weeks of followup, the patient had fully recovered to a normal state. CONCLUSION: CPM is a potentially fatal neurological condition and can occur in uncontrolled diabetes mellitus. Early diagnosis and timely treatment are crucial for improving the prognosis. BioMed Central 2023-05-10 /pmc/articles/PMC10170667/ /pubmed/37165361 http://dx.doi.org/10.1186/s12902-023-01361-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Sun, Wen-Ping Wang, Ying-Di Gao, Song Wang, Yi-Fan Li, Da-Wei A rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
title | A rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
title_full | A rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
title_fullStr | A rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
title_full_unstemmed | A rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
title_short | A rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
title_sort | rare presentation of central pontine myelinolysis secondary to hyperglycaemia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170667/ https://www.ncbi.nlm.nih.gov/pubmed/37165361 http://dx.doi.org/10.1186/s12902-023-01361-y |
work_keys_str_mv | AT sunwenping ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT wangyingdi ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT gaosong ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT wangyifan ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT lidawei ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT sunwenping rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT wangyingdi rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT gaosong rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT wangyifan rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia AT lidawei rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia |